Example: Heart Attack

Search clinical trials for: Complement C1 Inactivator Proteins

Total 47 results

NCT01275976

Terminated

Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Conditions: Trauma; Inflammation; Sepsis; Multiple Organ Dysfunction Syndrome
NCT00785018

Completed

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

Conditions: Endotoxemia; Inflammation; Multi Organ Dysfunction Syndrome
NCT01759602

Completed

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Conditions: Neuromyelitis Optica
NCT00292981

Completed

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Conditions: Hereditary Angioedema
NCT01766414

Completed

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II

Conditions: Innate Immune Response; Endotoxemia; Inflammation; Sepsis
NCT03221842

Active, not recruiting

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Conditions: Antibody-mediated Rejection
NCT02584959

Completed

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Conditions: Hereditary Angioedema (HAE)
NCT01147302

Completed

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Conditions: Graft Rejection
NCT02316353

Completed

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Conditions: Hereditary Angioedema Types I and II
NCT03576469

Recruiting

A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

Conditions: CVI - Common Variable Immunodeficiency
NCT01912456

Completed

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Conditions: Hereditary Angioedema Types I and II
NCT02869347

Completed

Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects

Conditions: Acute Kidney Injury
NCT01576523

Completed

A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Conditions: Hereditary Angioedema Types I and II
NCT01005888

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Conditions: Hereditary Angioedema
NCT00289211

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Conditions: Hereditary Angioedema
NCT00432510

Completed

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Conditions: Hereditary Angioedema
NCT00462709

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Conditions: Hereditary Angioedema
NCT00438815

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Conditions: Hereditary Angioedema
NCT00168103

Completed

Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Conditions: Hereditary Angioedema
NCT01108848

Completed

Patient Registry Study of Berinert® in Normal Clinical Practice

Conditions: Includes: Hereditary Angioedema
NCT01134510

Completed

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Conditions: Kidney Transplantation
NCT02663687

Completed

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Conditions: Hereditary Angioedema (HAE)
NCT02134314

Completed

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Conditions: End Stage Renal Disease; Kidney Failure; Delayed Graft Function; Ischemic Reperfusion Injury
NCT01426763

Completed

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

Conditions: Hereditary Angioedema
NCT01756157

Completed

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Conditions: Hereditary Angioedema (HAE)